Danaher Corporation ( DHR) - Key Metrics
DHR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $9.67 | $1.69 | $2.99 | $2.47 |
| 2025Q3 | $8.52 | $1.28 | $2.34 | $1.93 |
| 2025Q2 | $8.28 | $0.77 | $1.87 | $1.52 |
| 2025Q1 | $8.01 | $1.33 | $1.81 | $1.47 |
DHR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 18.88% | 33.82 |
| 2025Q3 | 25.22% | 36.17 |
| 2025Q2 | 41.26% | 64.16 |
| 2025Q1 | 20.34% | 38.64 |
DHR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.84% | ? |
| 2025Q4 | 1.08% | 0.14% |
| 2025Q3 | 1.04% | 0.17% |
| 2025Q2 | 0.77% | 0.16% |
| 2025Q1 | 0.71% | 0.13% |
DHR
List: Contenders
Price: $179.14
Dividend Yield: 0.73%
Forward Dividend Yield: 0.89%
Payout Ratio: 19.89%
Dividend Per Share: 1.60 USD
Earnings Per Share: 5.16 USD
P/E Ratio: 34.35
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.8 million
Ebitda: 1.3 billionMarket Capitalization: 140.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 34
DGR3: 8.80%
DGR5: 11.15%
DGR10: 30.00%
DGR20: 30.00%